Dermatology

Bristol-Myers Squibb Company and Roche have entered into a clinical collaboration agreement for the evaluation of the utility of Bristol-Myers Squibb’s CTLA-4 inhibitor, YERVOY (ipilimumab), when combined with Roche’s investigation oral BRAF inhibitor, vemurafenib, in the treatment of patients suffering from a specific type of metastatic melanoma.

Technology giant Hewlett-Packard Development Co. (HP) recently released a drug research application for the company’s inkjet technology that reportedly enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.

The new software is expected to be launched in 2011 and will be based on the Diaceutics Fusion platform and the London Genetics Biomarker Pathway platform

Beckman Coulter Genomics has introduced the SPRIworks Fragment Library System II.

The anti-PTH antibody forms the basis of an existing relationship between AbD Serotec and a leading diagnostic company which markets clinical parathyroid hormone assays

The U.S. Court of Appeals for the Federal Circuit recently rendered a decision in Ortho-McNeil Pharmaceutical Inc. v. Lupin Pharmaceuticals Inc. on the question of whether separate enantiomers can have “first commercial marketing or use” status for purposes of patent term extension under 35 U.S.C. § 156.

GripTips are a next- generation range of pipette tips that ensure the perfect connection between pipette and tip. GripTips have been engineered to provide unmatched high lateral resistance.

CellCentric licenses novel epigenetic discovery program to Takeda

The ScrewCap DeCapper available from Micronic Europe BV is a compact, automated instrument for the opening and closing of screw-capped tubes (0.5 - 1.4ml).

Fluxion Biosciences, a provider of cellular analysis tools for use in life science research and drug discovery applications, announced in December the expansion of its sales and service network into Asia.

Qiagen acquires DxS in deal worth up to $130 million

CDI reprograms blood cells into stem cells using a small volume of human blood; expands drug testing agreement with Roche